2025
Incidence of Dysphagia and Comorbidities in Patients with Cervical Dystonia, Analyzed by Botulinum Neurotoxin Treatment Exposure
Barbano R, Jabbari B, Sadeghi M, Ukah A, Yue E, Ifantides K, Huang N, Swope D. Incidence of Dysphagia and Comorbidities in Patients with Cervical Dystonia, Analyzed by Botulinum Neurotoxin Treatment Exposure. Toxins 2025, 17: 148. PMID: 40137921, PMCID: PMC11945862, DOI: 10.3390/toxins17030148.Peer-Reviewed Original ResearchConceptsIncidence of dysphagiaCervical dystoniaComorbid conditionsContinuous health plan enrollmentCohort entry dateRate of dysphagiaRetrospective cohort studyPre-existing dysphagiaHealth plan enrollmentRisk factors of dysphagiaFactors of dysphagiaReal-world studyPotential adverse eventsPotential risk factorsPatient-level dataReal-world analysisAdverse eventsCD patientsCohort studyComorbid neurological conditionsLongitudinal patient-level dataCD diagnosisDysphagiaDysphagia riskPatients
2018
Botulinum Toxin Treatment of Movement Disorders
Safarpour Y, Jabbari B. Botulinum Toxin Treatment of Movement Disorders. Current Treatment Options In Neurology 2018, 20: 4. PMID: 29478149, DOI: 10.1007/s11940-018-0488-3.Peer-Reviewed Original ResearchTask-specific dystoniaMovement disordersHemifacial spasmBotulinum toxin treatmentMovement disorder expertsHigh-quality studiesAutonomic dysfunctionOromandibular dystoniaCervical dystoniaPain disordersBoNT therapyRest tremorLaryngeal dystoniaVocal ticsToxin treatmentTourette syndromeDystoniaDisorder expertsEssential tremorAmerican AcademyTherapeutic agentsFirst choiceEfficacyDisordersBlepharospasm
2008
Botulinum neurotoxins in the treatment of refractory pain
Jabbari B. Botulinum neurotoxins in the treatment of refractory pain. Nature Reviews Neurology 2008, 4: 676-685. PMID: 19043424, DOI: 10.1038/ncpneuro0948.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply